...
首页> 外文期刊>Journal of Diabetes and Metabolic Disorders >Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics
【24h】

Effect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics

机译:亚油酸和维生素E共轭对超重2型糖尿病患者血糖控制,身体成分和炎性标志物的影响

获取原文
           

摘要

Background The healthy properties of conjugated linoleic acid (CLA) such as weight loss, reducing cardiovascular risk factors and inflammation have been reported. The trans-10, cis-12 CLA isomer is related to increasing insulin resistance, but the effects of cis-9, trans-11 isomer is not clear. The aim of this study was to investigate the effects of CLA with and without Vitamin E on body weight, body composition, glycemic index, inflammatory and coagulation factors, lipid profile, serum leptin and adiponectin, malondialdehyde (MDA), and blood pressure in type2 diabetes. Methods 56 patients with type2 diabetes were included in 8 week double-blind control trial that used metformin. They randomly divided into three groups: CLA + VitE, CLA + VitE placebo, CLA placebo + VitE placebo. All variables, anthropometric measurements, and body composition were evaluated at the beginning and the end of study. Statistical analysis and analysis of dietary data were performed using SPSS and nutritionist IV software, respectively. Results There were not any significant differences in variable changes among three groups. However, there was a trend to increase in MDA and decrease in apoB100 among CLA consumers. Conclusion The results of this study showed that administration of CLA supplementation for 8 weeks does not affect any indicators of metabolic control in overweight type2 diabetic patients.
机译:背景技术已经报道了共轭亚油酸(CLA)的健康特性,例如体重减轻,减少心血管危险因素和炎症。反式10,顺式12 CLA异构体与胰岛素抵抗的增加有关,但顺式9,反式11异构体的作用尚不清楚。本研究的目的是研究含或不含维生素E的CLA对2型体重,体重,血糖指数,炎症和凝血因子,脂质分布,血清瘦素和脂联素,丙二醛(MDA)和血压的影响糖尿病。方法采用二甲双胍的8周双盲对照试验纳入56例2型糖尿病患者。他们随机分为三组:CLA + VitE,CLA + VitE安慰剂,CLA安慰剂+ VitE安慰剂。在研究开始和结束时评估所有变量,人体测量学和身体成分。分别使用SPSS和Nutritionist IV软件进行统计分析和饮食数据分析。结果三组间变量变化无明显差异。但是,在CLA消费者中,MDA呈上升趋势,而apoB100呈下降趋势。结论这项研究的结果表明,在超重的2型糖尿病患者中,连续8周补充CLA不会影响任何代谢控制指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号